Gilead Sciences

US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment

Read more

EMA validates Gilead’s Marketing Authorisation Application for Lenacapavir

Read more

China Junshi’s potential COVID drug shows promise in small trial

Read more

Gilead withdraws use of Zydelig to treat cancer

Read more

Gilead submits Biologics Licence Application to USFDA for Bulevirtide

Read more

Gilead Sciences launches Asia Pacific All4LIVER Grant 2021

Read more

  India to import 4.5 lakh vials of Remdesivir

Read more

Gilead Sciences to support expansion of local production capacity of  Remdesivir  in India 

Read more

Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer

Read more

Gilead gets US FDA nod for Trodelvy to treat metastatic triple-negative breast cancer

Read more